Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that new data from studies on the Company’s proprietary Sebacia Microparticles will be featured in three separate presentations during the 39th Annual Conference of the American Society for Laser Medicine and Surgery.

Read More